Skip to main content
Log in

Risk Factors for Early Revision After Primary Total Hip Arthroplasty in Medicare Patients

Clinical Orthopaedics and Related Research®

Abstract

Background

Patient, surgeon, health system, and device factors are all known to influence outcomes in THA. However, patient-related factors associated with an increased risk of early failure are poorly understood, particularly in elderly patients.

Questions/purposes

We identified specific demographic and clinical characteristics associated with increased risk of early revision in Medicare patients with THA.

Methods

The Medicare 5% national sample administrative database was used to calculate the relative risk of revision within 12 months following primary THA as a function of baseline medical comorbidities in 56,030 Medicare patients who underwent primary THA between 1998 and 2010. The impact of 29 comorbid conditions on risk of early revision was examined using Cox regression, controlling for age, sex, race, US Census region, socioeconomic status, and all other baseline comorbidities.

Results

Depression, rheumatologic disease, psychoses, renal disease, chronic urinary tract infection, and congestive heart failure were associated with revision THA within 12 months of the index arthroplasty (p ≤ 0.038 for all comparisons; risk factors listed in order of significance).

Conclusions

This information is important when counseling elderly patients with THA regarding the risk of early failure and for risk stratifying publicly reported outcomes in Medicare patients with THA.

Level of Evidence

Level II, prognostic study. See Instructions for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker PN, Deehan DJ, Lees D, Jameson S, Avery PJ, Gregg PJ, Reed MR. The effect of surgical factors on early patient-reported outcome measures (PROMS) following total knee replacement. J Bone Joint Surg Br. 2012;94:1058–1066.

    Article  CAS  PubMed  Google Scholar 

  2. Bozic KJ, Bashyal RK, Anthony SG, Chiu V, Shulman B, Rubash HE. Is administratively coded comorbidity and complication data in total joint arthroplasty valid? Clin Orthop Relat Res. 2013;471:201–205.

    Article  PubMed  Google Scholar 

  3. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:128–133.

    Article  PubMed  Google Scholar 

  4. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012;94:794–800.

    PubMed  Google Scholar 

  5. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare and Medicaid programs: hospital outpatient prospective payment; ambulatory surgical center payment; hospital value-based purchasing program; physician self-referral; and patient notification requirements in provider agreements. Final rule with comment period. Fed Regist. 2011;76:74122–74584.

  6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.

    Article  CAS  PubMed  Google Scholar 

  7. Conroy JL, Whitehouse SL, Graves SE, Pratt NL, Ryan P, Crawford RW. Risk factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty. 2008;23:867–872.

    Article  PubMed  Google Scholar 

  8. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.

    Article  CAS  PubMed  Google Scholar 

  9. Goroll AH, Schoenbaum SC. Payment reform for primary care within the accountable care organization: a critical issue for health system reform. JAMA. 2012;308:577–578.

    Article  CAS  PubMed  Google Scholar 

  10. Graves SE, Rothwell A, Tucker K, Jacobs JJ, Sedrakyan A. A multinational assessment of metal-on-metal bearings in hip replacement. J Bone Joint Surg Am. 2011;93(suppl 3):43–47.

    PubMed  Google Scholar 

  11. Graw BP, Woolson ST, Huddleston HG, Goodman SB, Huddleston JI. Minimal incision surgery as a risk factor for early failure of total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2372–2376.

    Article  PubMed  Google Scholar 

  12. Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med. 1990;323:725–731.

    Article  CAS  PubMed  Google Scholar 

  13. Karlson EW, Mandl LA, Aweh GN, Sangha O, Liang MH, Grodstein F. Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med. 2003;114:93–98.

    Article  PubMed  Google Scholar 

  14. Koenig K, Huddleston JI 3rd, Huddleston H, Maloney WJ, Goodman SB. Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. J Arthroplasty. 2012;27:1402–1407.e1.

    PubMed  Google Scholar 

  15. Lubbeke A, Katz JN, Perneger TV, Hoffmeyer P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol. 2007;34:394–400.

    PubMed  Google Scholar 

  16. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24:105–109.

    Article  PubMed  Google Scholar 

  17. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT. Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop Relat Res. 2010;468:3070–3076.

    Article  PubMed  Google Scholar 

  18. Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010;92:929–934.

    Article  CAS  PubMed  Google Scholar 

  19. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–1715.

    Article  PubMed  Google Scholar 

  20. Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI, Fevang BT. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken). 2010;62:473–479.

    Article  PubMed  Google Scholar 

  21. Sheng PY, Konttinen L, Lehto M, Ogino D, Jamsen E, Nevalainen J, Pajamaki J, Halonen P, Konttinen YT. Revision total knee arthroplasty: 1990 through 2002: a review of the Finnish arthroplasty registry. J Bone Joint Surg Am. 2006;88:1425–1430.

    Article  PubMed  Google Scholar 

  22. Sibanda N, Copley LP, Lewsey JD, Borroff M, Gregg P, MacGregor AJ, Pickford M, Porter M, Tucker K, van der Meulen JH. Revision rates after primary hip and knee replacement in England between 2003 and 2006. PLoS Med. 2008;5:e179.

    Article  PubMed Central  PubMed  Google Scholar 

  23. VanLare JM, Conway PH. Value-based purchasing–national programs to move from volume to value. N Engl J Med. 2012;367:292–295.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin J. Bozic MD, MBA.

Additional information

One of the authors (EL) certifies that he, or a member of his immediate family, has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to USD 1,000,000, from Exponent, Inc (Menlo Park, CA, USA). One of the authors (SMK) certifies that he, or a member of his immediate family, has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to USD 1,000,000, from Exponent, Inc (Philadelphia, PA, USA). One of the authors (TPV) certifies that he, or a member of his immediate family, has received or may receive payments or benefits, during the study period, an amount of USD 10,000 to USD 100,000, from DePuy Orthopaedics, Inc (Warsaw, IN, USA). One of the authors (DJB) certifies that he, or a member of his immediate family, has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to USD 1,000,000, from DePuy Orthopaedics, Inc.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.

Each author certifies that the institution where the work was performed approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

This work was performed at University of California, San Francisco (San Francisco, CA, USA) and Exponent, Inc (Menlo Park, CA, USA, and Philadelphia, PA, USA).

About this article

Cite this article

Bozic, K.J., Lau, E., Ong, K. et al. Risk Factors for Early Revision After Primary Total Hip Arthroplasty in Medicare Patients. Clin Orthop Relat Res 472, 449–454 (2014). https://doi.org/10.1007/s11999-013-3081-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-013-3081-9

Keywords

Navigation